Skip to main content

ADVERTISEMENT

Prostate Cancer

Dr Chi Discusses Final Results Following the TITAN Study
Videos
02/16/2021
Kim Chi, MD, discusses final analysis results from the phase 3 TITAN trial of apalutamide vs placebo for patients with metastatic CSPC receiving ADT.
Kim Chi, MD, discusses final analysis results from the phase 3 TITAN trial of apalutamide vs placebo for patients with metastatic CSPC receiving ADT.
Kim Chi, MD, discusses final...
02/16/2021
Oncology
News
02/02/2021
Adding ADT to radiotherapy salvage treatment reduces clinical progression and death in patients with prostate cancer.
Adding ADT to radiotherapy salvage treatment reduces clinical progression and death in patients with prostate cancer.
Adding ADT to radiotherapy...
02/02/2021
Oncology
News
01/29/2021
Ultrahypofractionated RT yielded no increase in toxicities versus conventionally fractionated or moderately hypofractionated RT.
Ultrahypofractionated RT yielded no increase in toxicities versus conventionally fractionated or moderately hypofractionated RT.
Ultrahypofractionated RT yielded...
01/29/2021
Oncology
News
01/12/2021
Findings from a retrospective study suggest elevated GGT as an adverse prognosticator in patients with metastatic CRPC receiving enzalutamide.
Findings from a retrospective study suggest elevated GGT as an adverse prognosticator in patients with metastatic CRPC receiving enzalutamide.
Findings from a retrospective...
01/12/2021
Oncology
News
01/01/2021
Risk for dementia and depression is higher among patients who underwent ADT for prostate cancer than in those who did not.
Risk for dementia and depression is higher among patients who underwent ADT for prostate cancer than in those who did not.
Risk for dementia and depression...
01/01/2021
Oncology
Alexandra Sokolova, MD, Talks Germline Testing for Veterans With Metastatic Prostate Cancer
Videos
12/28/2020
Dr Sokolova highlights a systematic approach to germline testing in veterans with metastatic prostate cancer.
Dr Sokolova highlights a systematic approach to germline testing in veterans with metastatic prostate cancer.
Dr Sokolova highlights a...
12/28/2020
Oncology
News
01/17/2020
For patients with bone metastases from CRPC treated with bone-targeted radioisotopes (RIs), there may be survival benefits with α-emitting vs β-emitting RIs.
For patients with bone metastases from CRPC treated with bone-targeted radioisotopes (RIs), there may be survival benefits with α-emitting vs β-emitting RIs.
For patients with bone...
01/17/2020
Oncology
News
11/08/2019
Study findings suggest a need for increased awareness of PSA suppression induced by the use of 5α-reductase inhibitors in older adults with prostate cancer.
Study findings suggest a need for increased awareness of PSA suppression induced by the use of 5α-reductase inhibitors in older adults with prostate cancer.
Study findings suggest a need...
11/08/2019
Oncology
Interview
10/10/2019
Daniel Gioeli, PhD, and colleagues have found a potential key to regulating the progression of prostate cancer.
Daniel Gioeli, PhD, and colleagues have found a potential key to regulating the progression of prostate cancer.
Daniel Gioeli, PhD, and...
10/10/2019
Oncology
Videos
09/24/2019
David Quinn, MD, discusses the clinical significance of the EORTC PEACE III clinical trial.
David Quinn, MD, discusses the clinical significance of the EORTC PEACE III clinical trial.
David Quinn, MD, discusses the...
09/24/2019
Oncology